Cardiac Surgery Department, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.
Cardiovasc Ther. 2011 Dec;29(6):395-403. doi: 10.1111/j.1755-5922.2010.00219.x. Epub 2010 Aug 16.
Our aim was to evaluate the relative safety and efficacy of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass grafts (CABG) for the treatment of ostial right coronary stenosis (ORCS) lesions.
Three hundred fifty-nine cases of ORCS lesion were treated via CABG (n = 232) or PCI (n = 127) procedures. Propensity scores for undergoing the CABG procedure were estimated and used to match 105 pairs of patients between the two groups. Kaplan-Meier major adverse cardiac and cerebrovascular events (MACCE)-free curves were constructed to compare long-term MACCE-free survival between the two groups.
For the 105 propensity-matched pairs, patients were more likely to undergo repeat revascularization with CABG in the PCI group than in the CABG group during the first 30 days (4 cases vs. 0 case, P= 0.043, χ(2) = 4.08) and the 1-year follow-up (5 cases vs. 0 case, P= 0.02, χ(2) = 5.17). With a mean follow-up of 12.04 ± 6.47 months and a total of 210.67 patient-years, the freedom from MACCE in the CABG group was significantly higher than that in the PCI group (Log rank test, χ(2) = 4.48, P= 0.03). There were no significant differences in the rates of death, myocardial infarction, nonfatal stroke, death/myocardium infarction/stroke, or repeated PCI between the two groups during the first 30 days and during the 1-year follow-up period.
For OCRS lesions, CABG provided greater protection than PCI procedure in terms of freedom from MACCE, mainly due to the reduced number of repeated revascularization procedures. CABG should be considered as first-choice revascularization strategy for ORCS lesions.
本研究旨在评估药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)治疗开口右冠状动脉狭窄(ORCS)病变的相对安全性和有效性。
359 例 ORCS 病变患者分别接受 CABG(n=232)或 PCI(n=127)治疗。估计进行 CABG 手术的倾向评分,并用于匹配两组 105 对患者。构建 Kaplan-Meier 主要不良心脑血管事件(MACCE)无事件曲线,比较两组患者的长期 MACCE 无事件生存率。
在 105 对倾向评分匹配的患者中,PCI 组患者在术后 30 天内(4 例 vs. 0 例,P=0.043,χ(2)=4.08)和 1 年随访期间(5 例 vs. 0 例,P=0.02,χ(2)=5.17)更倾向于接受再次血运重建。平均随访 12.04±6.47 个月,共计 210.67 患者-年,CABG 组 MACCE 无事件生存率显著高于 PCI 组(Log rank 检验,χ(2)=4.48,P=0.03)。两组患者在术后 30 天内和 1 年随访期间,死亡率、心肌梗死、非致死性卒中和死亡/心肌梗死/卒中等主要不良心脑血管事件的发生率以及再次 PCI 率无显著差异。
对于 ORCS 病变,CABG 比 PCI 更能提供 MACCE 无事件的保护,主要是由于重复血运重建的数量减少。对于 ORCS 病变,CABG 应作为首选血运重建策略。